Global ECG Stress Test Market size will expand substantially through 2032. Growing geriatric population and the higher susceptibility of aging people to cardiovascular diseases such as stroke, cardiac arrest, and others have increased the need for ECG stress tests. As per the WHO, 1 in every 6 people across the globe will be 60 years and above by 2030.

Industry contenders in this field are emphasizing mergers and acquisition strategies to extend their footprint. For instance, in July 2022, Becton Dickinson and Co., an American multinational medical technology company, completed the acquisition of Parata Systems, a leader in the pharmacy automation portfolio space. This acquisition will help the company deliver smart and connected care technologies.

The overall ECG stress test market is classified based on product, end-use, and region.

In terms of product, stress blood pressure monitors market value will amass substantial gains through 2032. High accuracy of these monitors has increased their adoption. Moreover, the rising prevalence of cardiovascular disorders globally has further increased the need for these monitors. As per the CDC, stroke is diagnosed in over 795,000 people every year in the U.S. alone. Stress blood pressure monitors have undergone several upgrades and now boast advanced features.

For individuals with hypertension or other cardiovascular conditions, stress blood pressure monitors help evaluate the effectiveness of medication or lifestyle interventions. It helps determine the presence of conditions such as hypertension, hypotension, or irregular blood pressure fluctuations.

With respect to end-use, the ECG stress test market size from the ambulatory surgical centers segment will expand notably through 2032. High availability of cost-effective treatment solutions in these facilities for cardiovascular disorders is contributing to segment expansion. These facilities are designed for outpatient procedures, implying they can provide faster and more efficient services than hospitals. They are also equipped with cutting-edge tools for accurate disease diagnosis.

On the regional front, the Asia Pacific ECG stress test market share will grow at a significant CAGR from 2023 to 2032. High incidence rate of cardiovascular disorders has increased the demand for ECG stress tests in the region. Moreover, favorable government support towards the healthcare sector, in line with a rapidly aging population, is further positively affecting the regional outlook. Governments across several regional economies are also investing significantly in the medical device sector, which may help carve a healthy growth trajectory for the regional industry.